A dynamic and systematic analysis was set up in April 2020 to follow the progress of registered clinical trials concerning the vaccine and the therapeutic drug candidates against COVID-19. Vaccine and drug development involves multiple phases, typically taking more than five years to ensure the safety and efficacy of the new compound.
Uhakiki changamani, wa kimfumo ulianzishwa mnamo Aprili 2020 kufuatilia maendeleo ya majaribio yaliyosajiliwa ya kimatibabu ya chanjo ya COVID-19 na dawa zilizoteuliwa za matibabu. Utengenezaji wa chanjo na dawa ni mchakato uaohusisha hatua nyingi, unaohitaji kwa kawaida zaidi ya miaka mitano ili kuhakikisha usalama na kemikali mpya.